Culture conversion at 2 months among patients with rifampicin-susceptible pulmonary tuberculosis: a prospective cohort study
J. Min (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), K. Lee (Cheongju, Republic of Korea), S. Kim (Cheongju, Republic of Korea), S. Jung (Daejeon, Republic of Korea)
Source: International Congress 2022 – Advances in epidemiology, diagnosis and treatment of tuberculosis
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Min (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), K. Lee (Cheongju, Republic of Korea), S. Kim (Cheongju, Republic of Korea), S. Jung (Daejeon, Republic of Korea). Culture conversion at 2 months among patients with rifampicin-susceptible pulmonary tuberculosis: a prospective cohort study. 757
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|